Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients

• Auteurs principaux: Johannes Matthaei (Auteur), Jürgen Brockmöller (Auteur), Werner Steimer (Auteur), Konstanze Pischa (Auteur), Stefan Leucht (Auteur), Maria Kullmann (Auteur), Ole Jensen (Auteur), Typhaine Ouethy (Auteur), Mladen Vassilev Tzvetkov (Auteur), Muhammad Rafehi (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The tricyclic antidepressant amitriptyline is frequently prescribed but its use is limited by its narrow therapeutic range and large variation in pharmacokinetics. Apart from interindividual differences in the activity of the metabolising enzymes cytochrome P450 (CYP) 2D6 and 2C19, genetic polymorph...